iAnthus Capital (ITHUF) Stock Price, News & Analysis

Company Overview

iAnthus Capital Holdings Inc. is a U.S.-focused cannabis company engaged in the cultivation, processing, distribution and retail sale of cannabis products. Through its operating subsidiaries, the company serves regulated medical and adult-use markets, where permitted, and manages cannabis dispensaries, cultivation facilities and processing operations.

The company’s product portfolio has included cannabis flower, pre-rolls, concentrates, edibles, tinctures, topicals and other cannabis-derived products. Its operations and brands have included MPX and state-specific retail and product offerings, with product availability varying according to local regulations.

Founded in 2014, iAnthus expanded through acquisitions and development of operations in multiple U.S. jurisdictions, including Florida, Maryland, Massachusetts and New York. The company completed a restructuring under Canada’s Companies’ Creditors Arrangement Act and emerged with a reorganized corporate structure. Available public information does not provide sufficient current detail to reliably summarize its present leadership team.

Key Stats

• Today's Range: $0.0036 to $0.0043
• 50-Day Range: N/A
• 52-Week Range: $0.0026 to $0.0133
• Volume: 9,625 shs
• Average Volume: 290,836 shs
• Market Capitalization: N/A
• P/E Ratio: 0.02
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

iAnthus Capital Stock Analysis - MarketRank™

iAnthus Capital scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for iAnthus Capital.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of iAnthus Capital is 0.02, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.93.

Price to Earnings Ratio vs. Sector

The P/E ratio of iAnthus Capital is 0.02, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.39.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

iAnthus Capital has a short interest ratio ("days to cover") of 0.02, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in iAnthus Capital has recently decreased by 1.36%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

iAnthus Capital does not currently pay a dividend.

Dividend Growth

iAnthus Capital does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

MarketBeat Follows

1 people have added iAnthus Capital to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, iAnthus Capital insiders have not sold or bought any company stock.

Percentage Held by Institutions

0.34% of the stock of iAnthus Capital is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:ITHUF
• CIK: 1643154
• Web: ianthus.com
• Phone: 646-518-9411
• Fax: N/A
• Employees: 1,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 0.02
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A